Market Cap 577.04M
Revenue (ttm) 187.34M
Net Income (ttm) -9.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.32%
Debt to Equity Ratio 0.47
Volume 2,989,761
Avg Vol 978,466
Day's Range N/A - N/A
Shares Out 45.54M
Stochastic %K 8%
Beta 1.00
Analysts Strong Sell
Price Target $24.29

Company Profile

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral...

Industry: Medical Devices
Sector: Healthcare
Phone: 386 462 6800
Fax: 386 462 6801
Address:
13631 Progress Boulevard, Suite 400, Alachua, United States
MikeyNJ
MikeyNJ Aug. 5 at 2:02 PM
$AXGN Very good earnings report. The September BLA is all but a certainty. It's no secret the company has retained investment bankers. A 50% premium to today's price is a pretty good bet. Would not be surprised to see a $21 buyout in the very near term. Hold those shares.
0 · Reply
dustin1101
dustin1101 Aug. 5 at 1:37 PM
$AXGN Who’s selling under $14 with good earnings and pdufa run up coming shortly? lol
1 · Reply
TheSilverBullitt
TheSilverBullitt Aug. 5 at 12:43 PM
$AXGN "I was hoping to start with a little bit more color on breast" "underlying trend in breast", Nice Frank.
0 · Reply
TheSilverBullitt
TheSilverBullitt Aug. 5 at 12:32 PM
$AXGN should be $16 in all fairness
0 · Reply
topstockalerts
topstockalerts Aug. 5 at 12:14 PM
$AXGN heating up…
0 · Reply
mikesterz7
mikesterz7 Aug. 5 at 11:30 AM
$AXGN 🚨 Revenue growth of 18.3% YoY to $56.7 million in Q2 2025 Achieved profitability with $0.6M net income vs $1.9M loss in Q2 2024 Improved gross margin to 74.2% from 73.8% YoY Expanded insurance coverage by 17 million new covered lives in 2025 Raised full-year revenue guidance to 17% growth ($219M) Expected to be net cash flow positive for full year 2025 Cash and investments decreased to $35.9M from $39.5M since December 2024 Anticipated one-time BLA approval costs to impact gross margin by 1%
0 · Reply
TheSilverBullitt
TheSilverBullitt Aug. 5 at 11:17 AM
$AXGN Solid earnings
0 · Reply
jlove0303
jlove0303 Aug. 5 at 11:06 AM
$AXGN Fantastic earnings TBH
0 · Reply
jlove0303
jlove0303 Aug. 5 at 11:06 AM
$AXGN Second Quarter Financial Results •Second quarter revenue was $56.7 million, an 18.3% increase compared to the second quarter of 2024, and a 16.7% increase over the first quarter of 2025. •For the second quarter of 2025, gross margin was 74.2%, up from 73.8% for the second quarter of 2024, and up from 71.9% in the first quarter of 2025. •Net income for the quarter was $0.6 million, or $0.01 per share, compared to a Net loss of $1.9 million, or $0.04 per share for the second quarter of 2024. •Adjusted net income for the quarter was $5.7 million, or $0.12 per share, compared to $2.0 million, or $0.05 per share, for the second quarter of 2024. •Adjusted EBITDA was $9.3 million for the quarter, compared to $5.6 million for the second quarter of 2024. •The balance of cash and cash equivalents, restricted cash, and investments at June 30, 2025, was $35.9 million, as compared to a balance of $39.5 million at December 31, 2024.
0 · Reply
jlove0303
jlove0303 Aug. 4 at 8:50 PM
$AXGN hmmmm....earnings leaked?
1 · Reply
Latest News on AXGN
Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 1:15 PM EDT - 32 minutes ago

Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript


Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript

May 9, 2025, 3:21 PM EDT - 3 months ago

Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript


Axogen, Inc. Reports 2025 First Quarter Financial Results

May 8, 2025, 7:05 AM EDT - 3 months ago

Axogen, Inc. Reports 2025 First Quarter Financial Results


Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 1:58 PM EST - 5 months ago

Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript


Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 25, 2025, 7:10 AM EST - 5 months ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th


Axogen: Well Placed To Capitalize Growth At Higher Multiples

Jan 6, 2025, 8:01 PM EST - 7 months ago

Axogen: Well Placed To Capitalize Growth At Higher Multiples


Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:53 AM EST - 9 months ago

Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript


Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 2:10 PM EDT - 1 year ago

Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript


Axogen, Inc. Announces New Leadership Appointments

Aug 8, 2024, 7:05 AM EDT - 1 year ago

Axogen, Inc. Announces New Leadership Appointments


AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript

May 5, 2024, 1:21 AM EDT - 1 year ago

AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript


Axogen, Inc Reports First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc Reports First Quarter 2024 Financial Results


AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 11:03 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript


Axogen Announces Promotions on Research and Development Team

Jan 4, 2024, 4:35 PM EST - 1 year ago

Axogen Announces Promotions on Research and Development Team


Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 26, 2023, 4:15 PM EST - 1 year ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors


Axogen Announces Transition of Finance Team Leadership

Dec 6, 2023, 7:00 AM EST - 1 year ago

Axogen Announces Transition of Finance Team Leadership


AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 9:49 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Third Quarter Financial Results

Nov 7, 2023, 7:00 AM EST - 1 year ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results


Axogen to Participate at Upcoming Investor Conferences

Aug 31, 2023, 7:00 AM EDT - 2 years ago

Axogen to Participate at Upcoming Investor Conferences


AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 9:34 PM EDT - 2 years ago

AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Second Quarter Financial Results

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Axogen, Inc. Reports 2023 Second Quarter Financial Results


Axogen to Participate at Jefferies Healthcare Conference

May 24, 2023, 7:00 AM EDT - 2 years ago

Axogen to Participate at Jefferies Healthcare Conference


AxoGen, Inc. (AXGN) Q1 2023 Earnings Call Transcript

May 9, 2023, 10:58 AM EDT - 2 years ago

AxoGen, Inc. (AXGN) Q1 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 First Quarter Financial Results

May 9, 2023, 7:00 AM EDT - 2 years ago

Axogen, Inc. Reports 2023 First Quarter Financial Results


MikeyNJ
MikeyNJ Aug. 5 at 2:02 PM
$AXGN Very good earnings report. The September BLA is all but a certainty. It's no secret the company has retained investment bankers. A 50% premium to today's price is a pretty good bet. Would not be surprised to see a $21 buyout in the very near term. Hold those shares.
0 · Reply
dustin1101
dustin1101 Aug. 5 at 1:37 PM
$AXGN Who’s selling under $14 with good earnings and pdufa run up coming shortly? lol
1 · Reply
TheSilverBullitt
TheSilverBullitt Aug. 5 at 12:43 PM
$AXGN "I was hoping to start with a little bit more color on breast" "underlying trend in breast", Nice Frank.
0 · Reply
TheSilverBullitt
TheSilverBullitt Aug. 5 at 12:32 PM
$AXGN should be $16 in all fairness
0 · Reply
topstockalerts
topstockalerts Aug. 5 at 12:14 PM
$AXGN heating up…
0 · Reply
mikesterz7
mikesterz7 Aug. 5 at 11:30 AM
$AXGN 🚨 Revenue growth of 18.3% YoY to $56.7 million in Q2 2025 Achieved profitability with $0.6M net income vs $1.9M loss in Q2 2024 Improved gross margin to 74.2% from 73.8% YoY Expanded insurance coverage by 17 million new covered lives in 2025 Raised full-year revenue guidance to 17% growth ($219M) Expected to be net cash flow positive for full year 2025 Cash and investments decreased to $35.9M from $39.5M since December 2024 Anticipated one-time BLA approval costs to impact gross margin by 1%
0 · Reply
TheSilverBullitt
TheSilverBullitt Aug. 5 at 11:17 AM
$AXGN Solid earnings
0 · Reply
jlove0303
jlove0303 Aug. 5 at 11:06 AM
$AXGN Fantastic earnings TBH
0 · Reply
jlove0303
jlove0303 Aug. 5 at 11:06 AM
$AXGN Second Quarter Financial Results •Second quarter revenue was $56.7 million, an 18.3% increase compared to the second quarter of 2024, and a 16.7% increase over the first quarter of 2025. •For the second quarter of 2025, gross margin was 74.2%, up from 73.8% for the second quarter of 2024, and up from 71.9% in the first quarter of 2025. •Net income for the quarter was $0.6 million, or $0.01 per share, compared to a Net loss of $1.9 million, or $0.04 per share for the second quarter of 2024. •Adjusted net income for the quarter was $5.7 million, or $0.12 per share, compared to $2.0 million, or $0.05 per share, for the second quarter of 2024. •Adjusted EBITDA was $9.3 million for the quarter, compared to $5.6 million for the second quarter of 2024. •The balance of cash and cash equivalents, restricted cash, and investments at June 30, 2025, was $35.9 million, as compared to a balance of $39.5 million at December 31, 2024.
0 · Reply
jlove0303
jlove0303 Aug. 4 at 8:50 PM
$AXGN hmmmm....earnings leaked?
1 · Reply
jlove0303
jlove0303 Aug. 4 at 7:43 PM
$AXGN price action is so annoying. 92% held by insiders and tutes. I don't get it
0 · Reply
MikeyNJ
MikeyNJ Aug. 4 at 3:14 PM
$AXGN I will go out on a limb here... positive BLA outcome in September and this is bought at 52 week high at $21.
0 · Reply
Kaslee
Kaslee Aug. 4 at 11:37 AM
$AXGN what to expect on the earnings ? Is it good buy for today ?
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Aug. 1 at 5:44 PM
$AXGN bounce here
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Aug. 1 at 5:15 PM
$AXGN Adding here at 12.87 should see $30 in the near future.Very bullish.
0 · Reply
MGeronimo
MGeronimo Aug. 1 at 1:13 AM
$AXGN SHOULD ROCKET TO NEW 52 week high
0 · Reply
MGeronimo
MGeronimo Aug. 1 at 1:07 AM
$AXGN CORRECTION 13.09
0 · Reply
MGeronimo
MGeronimo Aug. 1 at 1:05 AM
$AXGN BASED IN AT 13.15
0 · Reply
Diamondhands42069
Diamondhands42069 Jul. 31 at 5:14 PM
$AXGN selling off every gain zero interest in options
0 · Reply
cl_ryan
cl_ryan Jul. 31 at 1:12 AM
$AXGN $AXOGEN Inc you guys have no clue who offered the 18/share, I do though. The deal is done unless a higher bidder comes through
2 · Reply
MGeronimo
MGeronimo Jul. 31 at 12:39 AM
$AXGN 5 year high is 22.14 we might break it soon
0 · Reply
MGeronimo
MGeronimo Jul. 30 at 11:47 PM
$AXGN added more at 13.00 a 20/200 golden cross and earnings should push it to a new 52 week high
0 · Reply